Chamomile (primarily German chamomile/Matricaria recutita) is a medicinal plant containing bioactive compounds including flavonoids (apigenin), sesquiterpenes, and volatile oils. It works primarily through GABAergic and sedative mechanisms, with apigenin binding to benzodiazepine receptors. Traditionally used for anxiety, sleep disorders, gastrointestinal issues, and topical wound healing.

Overview

Chamomile refers primarily to two species of flowering plants in the Asteraceae family: German chamomile (Matricaria chamomilla) and Roman chamomile (Chamaemelum nobile). German chamomile is the more commonly used variety in herbal medicine and dietary supplements. The plant has been employed therapeutically for thousands of years, with records of its use dating back to ancient Egypt, Greece, and Rome for treating a variety of ailments.

The primary bioactive compounds in chamomile include the terpenoids bisabolol and chamazulene, as well as the flavonoid apigenin. Apigenin is of particular pharmacological interest due to its ability to bind to benzodiazepine receptors in the brain, which is believed to underlie chamomile's mild anxiolytic and sedative effects. The essential oil also contains anti-inflammatory and antispasmodic compounds that contribute to its traditional use for digestive complaints.

Clinical research on chamomile has yielded promising but often preliminary results. Randomized controlled trials have demonstrated modest benefits for generalized anxiety disorder, sleep quality, and symptoms of mild depression. Topical chamomile preparations have shown efficacy for skin inflammation and wound healing. Chamomile is generally recognized as safe and is one of the most widely consumed herbal teas globally, though individuals with allergies to plants in the Asteraceae family should use it with caution.

Mechanism of Action

Apigenin — GABAergic & Benzodiazepine-Site Modulation

Chamomile (Matricaria chamomilla) flowers contain the flavonoid apigenin (4',5,7-trihydroxyflavone) as the primary anxiolytic constituent, alongside bisabolol, chamazulene, and matricin. Apigenin binds to the benzodiazepine site of GABA_A receptors with moderate affinity (Ki ~ 4 microM), acting as a partial agonist/positive allosteric modulator. Unlike full benzodiazepine agonists, apigenin produces anxiolysis without significant sedation, myorelaxation, or amnesia at typical doses, and does not produce dependence or tolerance with chronic use. This partial agonist profile selectively enhances GABAergic inhibition in amygdala and prefrontal cortical circuits mediating anxiety responses (PMID: 16423478).

Alpha-Bisabolol — Anti-Inflammatory & Cytoprotective

(-)-alpha-Bisabolol, a monocyclic sesquiterpene alcohol, inhibits cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) expression and activity, reducing prostaglandin E2 and leukotriene B4 production. Bisabolol also stabilizes lysosomal membranes, preventing release of proteolytic enzymes into inflamed tissues. It exhibits gastroprotective effects by enhancing mucosal prostaglandin E1 production and increasing mucus secretion, while directly relaxing gastrointestinal smooth muscle through calcium channel inhibition (PMID: 20832488).

Chamazulene — Antioxidant Artifact

Chamazulene is a blue azulene compound formed during steam distillation from its precursor matricin (a sesquiterpene lactone). It scavenges superoxide and hydroxyl radicals and inhibits leukotriene B4 synthesis in neutrophils by directly inhibiting 5-LOX. Chamazulene's intense blue color gives chamomile essential oil its characteristic appearance (PMID: 21824246).

HPA Axis & Cortisol Modulation

Chronic chamomile supplementation modulates the hypothalamic-pituitary-adrenal (HPA) axis by reducing basal cortisol levels and cortisol awakening response. Apigenin also inhibits monoamine oxidase (MAO-A) activity, increasing serotonin and norepinephrine availability in limbic structures and contributing to antidepressant effects observed in clinical trials for generalized anxiety disorder (PMID: 22894890).

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Allergic contact dermatitis: chamomile is a member of the Asteraceae/Compositae family and can cause skin reactions in sensitized individuals
• Mild gastrointestinal upset including nausea and stomach discomfort (uncommon with tea preparations)
• Drowsiness and sedation, consistent with its traditional use as a calming agent
• Eye irritation if chamomile tea or preparations are used as eye compresses (not recommended due to contamination risk)
• Mild headache in some individuals

Serious Adverse Effects

• Anaphylaxis: severe allergic reactions have been reported, particularly in individuals with known allergies to ragweed, chrysanthemums, marigolds, daisies, or other Asteraceae family plants
• Severe contact dermatitis and eczema flares in highly sensitive individuals
• Hepatotoxicity has been reported in rare cases with concentrated chamomile extracts, though causality is difficult to establish
• Emesis (vomiting) with ingestion of large quantities of chamomile oil
• Potential uterine stimulant effects at high doses, raising miscarriage concerns

Contraindications

• Known allergy to plants in the Asteraceae/Compositae family (ragweed, chrysanthemums, marigolds, daisies, asters)
• Pregnancy: chamomile has traditionally been considered an emmenagogue (uterine stimulant) and high doses or concentrated extracts should be avoided; occasional chamomile tea consumption is generally considered low-risk
• Pre-surgical patients: discontinue at least 2 weeks before surgery due to potential anticoagulant effects
• Hormone-sensitive conditions: chamomile contains weak phytoestrogenic compounds; use with caution in estrogen receptor-positive cancers

Drug Interactions

• Anticoagulants and antiplatelets (warfarin, heparin, aspirin): chamomile contains coumarin derivatives that may potentiate anticoagulant effects and increase bleeding risk
• Sedatives and CNS depressants (benzodiazepines, barbiturates, alcohol, opioids): additive sedation effects
• Cyclosporine: chamomile may affect CYP3A4 metabolism, potentially altering cyclosporine levels
• Tamoxifen and other anti-estrogen therapies: theoretical interference due to phytoestrogenic activity
• CYP1A2 and CYP3A4 substrates: chamomile may inhibit these enzymes, affecting metabolism of caffeine, theophylline, and various medications
• Iron supplements: tannins in chamomile tea may reduce non-heme iron absorption

Special Populations

• Infants and children: chamomile tea has been traditionally used for colic; however, use should be limited and dilute to avoid allergic reactions and excessive sedation
• Breastfeeding: occasional chamomile tea is likely safe; concentrated extracts are not recommended
• Elderly: sedative effects may increase fall risk, particularly when combined with other CNS depressants
• Atopic individuals: higher baseline risk of chamomile allergy; exercise caution

Pharmacokinetic Profile